Pricing

Seagen Inc.

0 followers ·
BOTHELL WA
Seagen is based out of Bothell. Discovers and develops monoclonal antibody-based therapeutic products for the treatment of cancer and immunologic diseases. As of Dec. 31, 2004, the company had three product candidates in clinical trials: SGN-30 (lymphoma); SGN-15 (non-small cell lung cancer); and SGN-40 (multiple myeloma).Whalewisdom has at least 3 13D filings, 2 13G filings, and 420 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2009-06-01. The notice included securities offered of Equity

Contact Info

Contact information is taken directly from publicly disclosed SEC filings.

Seagen Inc.
21823 30TH DRIVE SE
BOTHELL WA    98021

Business Phone: 4255274000
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Recent SEC Filings

Filing Date
15-12G 2023-12-26
SC 13D/A 2023-12-18
4 2023-12-18
4 2023-12-15
4 2023-12-15
4 2023-12-15
4 2023-12-15
4 2023-12-15
4 2023-12-15
4 2023-12-15

Current 13D/G Holdings

Stock Sector Shares Held Market Value Rank Source Source Date
Pieris Pharmaceuticals Inc HEALTH CARE 3,706,184 678,232 1 13G 2023-02-10